LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 211 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,665 | +8.4% | 27,783 | +30.4% | 0.02% | +33.3% |
| Q2 2023 | $1,536 | +27.3% | 21,310 | +18.0% | 0.01% | -33.3% |
| Q4 2022 | $1,207 | -99.8% | 18,063 | +220.2% | 0.02% | +200.0% |
| Q3 2022 | $486,000 | +38.5% | 5,642 | +145.3% | 0.01% | +20.0% |
| Q1 2021 | $351,000 | -42.7% | 2,300 | -62.7% | 0.01% | -16.7% |
| Q4 2020 | $613,000 | +94.0% | 6,165 | +86.1% | 0.01% | 0.0% |
| Q3 2020 | $316,000 | -71.0% | 3,312 | -66.0% | 0.01% | -78.6% |
| Q2 2020 | $1,091,000 | – | 9,751 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |